India's Laurus Labs hits near 1-1/2 year high

Alivus Life Sciences

03/04/2024 09:38

** Shares of pharmaceutical firm Laurus Labs  LAUL.NS  rise
as much as 7.9% to 448 rupees, highest since Nov. 28, 2022
    ** Stock on track for fourth consecutive session of gains
    ** Reuters could not immediately ascertain a reason for the
move
    ** Stock top gainer in Nifty pharma index  .NIPHARM , which
is trading flat
    ** Stock most active since Jan. 25; more than 6.9 mln shares
change hands by 1:59 p.m. IST, 3.9x the 30-day avg
    ** Avg rating of 10 analysts equivalent of "hold", median PT
is 333 rupees - LSEG data
    ** Among peers, Granules India  GRAN.NS  rated "strong buy"
while Glenmark Life Sciences  GLEM.NS  is rated "buy" - LSEG
    ** LAUL fell 8.8% in March quarter vs 12.9% rise in Nifty
pharma index



 (Reporting by Ashish Chandra in Bengaluru)
 ((ashish.chandra@thomsonreuters.com (+91 7982114624))